BACKGROUND: Surgery for potentially resectable stage IIIA-N2 non-small cell lung cancer(NSCLC) is controversial. For some, persistent N2 disease following induction therapy is a contraindication to resection. We examined outcomes of a well-selected surgical cohort of post-induction IIIA-N2 NSCLC patients with persistent N2 disease. METHODS: We retrospectively reviewed all resected clinical IIIA-N2 NSCLC patients from 2001-2018. Thorough pre-operative staging, including invasive mediastinal staging, was performed. Those with non-bulky N2 disease, appropriate restaging, and potential for a margin-negative resection were included. Post-resection, patients were classified as having persistent N2 disease or mediastinal downstaging (N2-\u3eN0/N1)...
Background: Surgical exploration in mediastinoscopy proven N2 non-small cell lung cancer (NSCLC) is ...
BACKGROUND: The accuracy of restaging in patients with stage IIIa non-small cell lung cancer aft...
ObjectiveThe role of surgery in the treatment of preoperatively diagnosed N2 non–small cell lung can...
BACKGROUND: Surgery for potentially resectable stage IIIA-N2 non-small cell lung cancer(NSCLC) is co...
OBJECTIVE: The surgical treatment of residual N2 disease following induction radio-chemotherapy (IT...
Objective: The role of surgery in patients with N2 non\u2013small cell lung cancer is debated. The a...
ObjectiveOptimal management of stage IIIA-N2 non–small cell lung cancer remains controversial. The s...
OBJECTIVES: Resection of N2a non-small-cell lung cancer (NSCLC) diagnosed preoperatively is controve...
【Abstract 】 The role of surgery in stage A-N2 non-small cell lung cancer (NSCLC) remains controversi...
ObjectiveThe role of surgery in patients with N2 non–small cell lung cancer is debated. The aim of t...
OBJECTIVE Surgical treatment of locally advanced non-small cell lung cancer including single or m...
Surgical treatment of locally advanced non-small cell lung cancer including single or multilevel N2 ...
Patients with stage IIIA-ipsilateral mediastinal lymph node involvement (N2) non\u2013small cell lun...
ObjectivesPatients achieving a mediastinal pathologic complete response with neoadjuvant chemotherap...
This study aims to analyze the outcome of patients with stage IIIA-N2 non small-cell lung cancer who...
Background: Surgical exploration in mediastinoscopy proven N2 non-small cell lung cancer (NSCLC) is ...
BACKGROUND: The accuracy of restaging in patients with stage IIIa non-small cell lung cancer aft...
ObjectiveThe role of surgery in the treatment of preoperatively diagnosed N2 non–small cell lung can...
BACKGROUND: Surgery for potentially resectable stage IIIA-N2 non-small cell lung cancer(NSCLC) is co...
OBJECTIVE: The surgical treatment of residual N2 disease following induction radio-chemotherapy (IT...
Objective: The role of surgery in patients with N2 non\u2013small cell lung cancer is debated. The a...
ObjectiveOptimal management of stage IIIA-N2 non–small cell lung cancer remains controversial. The s...
OBJECTIVES: Resection of N2a non-small-cell lung cancer (NSCLC) diagnosed preoperatively is controve...
【Abstract 】 The role of surgery in stage A-N2 non-small cell lung cancer (NSCLC) remains controversi...
ObjectiveThe role of surgery in patients with N2 non–small cell lung cancer is debated. The aim of t...
OBJECTIVE Surgical treatment of locally advanced non-small cell lung cancer including single or m...
Surgical treatment of locally advanced non-small cell lung cancer including single or multilevel N2 ...
Patients with stage IIIA-ipsilateral mediastinal lymph node involvement (N2) non\u2013small cell lun...
ObjectivesPatients achieving a mediastinal pathologic complete response with neoadjuvant chemotherap...
This study aims to analyze the outcome of patients with stage IIIA-N2 non small-cell lung cancer who...
Background: Surgical exploration in mediastinoscopy proven N2 non-small cell lung cancer (NSCLC) is ...
BACKGROUND: The accuracy of restaging in patients with stage IIIa non-small cell lung cancer aft...
ObjectiveThe role of surgery in the treatment of preoperatively diagnosed N2 non–small cell lung can...